LUCENCE DIAGNOSTICS
Lucence Diagnostics makes ultrasensitive and non-invasive liquid biopsy tests for cancer detection and treatment selection.
LUCENCE DIAGNOSTICS
Industry:
Biotechnology Health Care
Founded:
2016-01-01
Address:
Palo Alto, California, United States
Country:
United States
Website Url:
http://www.lucencedx.com
Total Employee:
11+
Status:
Active
Contact:
65 65925102
Email Addresses:
[email protected]
Official Site Inspections
http://www.lucencedx.com
- Host name: 172.67.172.216
- IP address: 172.67.172.216
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Lucence Diagnostics"
Lucence | Advancing Precision Cancer Care
Fight cancer with a single draw of blood. Lucence makes ultrasensitive and non-invasive Liquid Biopsy Tests for cancer detection and treatment.See details»
Lucence Launches LucenceINSIGHT to Detect Cancer …
PALO ALTO, May 9, 2023 – Lucence unveiled LucenceINSIGHTâ„¢, its pioneering multi-cancer early detection (MCED) blood test, at their US headquarters. The event was attended by Singapore’s Deputy Prime Minister, Coordinating …See details»
Lucence Diagnostics - Crunchbase Company Profile & Funding
Lucence Diagnostics makes ultrasensitive and non-invasive liquid biopsy tests for cancer detection and treatment selection. There is no recent news or activity for this profile. View …See details»
Lucence Management Team | Org Chart - RocketReach
Lucence employs 98 employees. The Lucence management team includes Jack Challis (Senior VP, US Operations), Christopher Wong (Vice President Medical Affairs), and Hilda Tan …See details»
Lucence Raises USD $20M Series A Led by IHH Healthcare to …
Nov 19, 2019 · Lucence is a genomic medicine company founded on a vision of a world without avoidable cancer deaths. The company develops non-invasive blood tests that achieve early …See details»
Lucence Diagnostics | Company | Mindmaps
Lucence Diagnostics is a genomic medicine company focused on personalizing cancer care. We invent a full spectrum of cancer diagnostics covering early-stage screening to late-stage …See details»
Lucence | Company | Mindmaps
Lucence is a company that produces Liquid Biopsy Tests for cancer detection and treatment. These tests are ultrasensitive and non-invasive, requiring only a single draw of blood.See details»
Lucence - Overview, News & Competitors | ZoomInfo.com
View Lucence (www.lucencedx.com) location in California, United States , revenue, industry and description. Find related and similar companies as well as employees by title and much more.See details»
Lucence Diagnostics - VentureRadar
Website: http://www.lucencedx.com/ Develops genetic-based diagnostic tools and solutions to facilitate informed decision-making and promote improved overall health outcomes. Bio tech …See details»
LiquidHALLMARK® - pcmpathology.org
LiquidHALLMARK® is the world’s first blood test that simultaneously detects multiple cancer-causing mutations and viruses in circulating tumor DNA (ctDNA) for cancer diagnosis and …See details»
Lucence’s Competitors, Revenue, Number of Employees, Funding …
Lucence’s Profile, Revenue and Employees. Lucence provides liquid biopsy tests and genetic counselling for cancer and tumor treatments. Lucence’s primary competitors include …See details»
Lucence Diagnostics to Develop AI Tools for Liver Cancer Treatment
SINGAPORE, March 11, 2019 /PRNewswire/ -- Lucence Diagnostics, a genomic medicine company focused on personalizing cancer care, today announced a new project to develop AI …See details»
Lucence Diagnostics Singapore Lab Receives CLIA Certification
Sep 29, 2019 · International precision medicine firm Lucence Diagnostics announced that it has received the Clinical Laboratory Improvement Amendments certification for its laboratory in …See details»
MEDx (Suzhou) and Lucence Partner to Co-Develop Cutting-Edge …
Nov 7, 2019 · SUZHOU, China-- ( BUSINESS WIRE )--MEDx (Suzhou) Translational Medicine, and Singapore-based Lucence - a leading genomic medicine company - today announced an …See details»
Sample Report for LiquidHALLMARK - pcmpathology.org
In the present LiquidHALLMARK® test, the resistance-conferring EGFR T790M, activating EGFR L858R and TP53 V216M mutations were detected at a frequency of 0.16%, 0.27% and 1.06% …See details»
LUCENCE DIAGNOSTICS LAUNCHES WORLD’S FIRST MOLECULAR …
Nov 12, 2018 · Lucence’s tests target the most common cancers in Asia using proprietary technology and clinical analytics. Its key operations are supported by an ISO15189 accredited …See details»
LucenceDx - S3 Portal
You need to enable JavaScript to run this app.See details»
GSK’s fully liquid Menveo meningococcal vaccine approved by …
1 day ago · GSK’s MenACWY vaccine has received regulatory approval in over 60 countries. 9 It offers evidence of immunogenicity with a well-characterised safety profile. 10,11 In the …See details»
MEDx (Suzhou) and Lucence Partner to Co-Develop Cutting-Edge …
Nov 7, 2019 · SUZHOU, China-- (BUSINESS WIRE)--MEDx (Suzhou) Translational Medicine, and Singapore-based Lucence - a leading genomic medicine company - today announced an …See details»
Find service organizations for existing homes - Canada
Nov 19, 2024 · Service organizations registered with Natural Resources Canada (NRCan) can help you plan energy-efficient retrofits and other improvements to your home. You must …See details»